Neoadjuvant chemotherapy in muscle invasive bladder cancer: Real world data on safety and outcome.

被引:0
|
作者
Panthula, Sree Vamsee Chetana [1 ]
Philip, Arun [1 ]
Keechilat, Pavithran [1 ]
Jose, Wesley Mannirathil [1 ]
机构
[1] Amrita Inst Med Sci, Kochi, Kerala, India
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e17036
引用
收藏
页数:2
相关论文
共 50 条
  • [21] EFFECT OF NEOADJUVANT CHEMOTHERAPY ON THE IMMUNE MICROENVIRONMENT IN MUSCLE INVASIVE BLADDER CANCER
    Ikarashi, Daiki
    Kitano, Shigehisa
    Tsuyukubo, Takashi
    Kato, Yoichiro
    Nakatsura, Tetsuya
    Maekawa, Shigekatsu
    Kato, Renpei
    Obara, Wataru
    JOURNAL OF UROLOGY, 2021, 206 : E998 - E998
  • [22] Sarcopenia and Response to Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
    Lyon, Timothy D.
    Frank, Igor
    Takahashi, Naoki
    Boorjian, Stephen A.
    Moynagh, Michael R.
    Shah, Paras H.
    Tarrell, Robert F.
    Cheville, John C.
    Viers, Boyd R.
    Tollefson, Matthew K.
    CLINICAL GENITOURINARY CANCER, 2019, 17 (03) : 216 - +
  • [23] Trends in utilization of neoadjuvant and adjuvant chemotherapy for muscle invasive bladder cancer
    McFerrin, Coleman
    Davaro, Facundo
    May, Allison
    Raza, Syed
    Siddiqui, Sameer
    Hamilton, Zachary
    INVESTIGATIVE AND CLINICAL UROLOGY, 2020, 61 (06) : 565 - 572
  • [24] Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
    Vasdev, N.
    Zargar, H.
    Fairey, A.
    Espiritu, P.
    Krabbe, L.
    Mongomery, J.
    Gandhi, N.
    Griffin, J.
    Yu, E.
    Campain, N.
    Xylinas, E.
    Horenblas, S.
    Yousef, D.
    Kassouf, W.
    Shariat, S.
    Aning, J.
    Wright, J.
    Holzbeierlein, J.
    Bivalacqua, T.
    Morgan, T.
    North, S.
    Borcas, D.
    Lotan, Y.
    Shah, J.
    Spiess, P.
    Van Rhijn, B.
    Daneshmand, S.
    Black, P.
    Thorpe, A. C.
    BJU INTERNATIONAL, 2014, 113 : 25 - 25
  • [25] DISEASE PROGRESSION DURING NEOADJUVANT CHEMOTHERAPY FOR MUSCLE INVASIVE BLADDER CANCER
    Mossanen, Matthew
    JOURNAL OF UROLOGY, 2013, 189 (04): : E764 - E764
  • [26] Adverse Events During Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer
    Salminen, Antti P.
    Perez, Ileana Montoya
    Klen, Riku
    Ettala, Otto O.
    Syvanen, Kari T.
    Elo, Laura L.
    Bostrom, Peter J.
    BLADDER CANCER, 2019, 5 (04) : 273 - 279
  • [27] Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer
    Zargar, Homayoun
    Espiritu, Patrick N.
    Fairey, Adrian S.
    Mertens, Laura S.
    Dinney, Colin P.
    Mir, Maria C.
    Krabbe, Laura-Maria
    Cookson, Michael S.
    Jacobsen, Niels-Erik
    Gandhi, Nilay M.
    Griffin, Joshua
    Montgomery, Jeffrey S.
    Vasdev, Nikhil
    Yu, Evan Y.
    Youssef, David
    Xylinas, Evanguelos
    Campain, Nicholas J.
    Kassouf, Wassim
    Dall'Era, Marc A.
    Seah, Jo-An
    Ercole, Cesar E.
    Horenblas, Simon
    Sridhar, Srikala S.
    McGrath, John S.
    Aning, Jonathan
    Shariat, Shahrokh F.
    Wright, Jonathan L.
    Thorpe, Andrew C.
    Morgan, Todd M.
    Holzbeierlein, Jeff M.
    Bivalacqua, Trinity J.
    North, Scott
    Barocas, Daniel A.
    Lotan, Yair
    Garcia, Jorge A.
    Stephenson, Andrew J.
    Shah, Jay B.
    van Rhijn, Bas W.
    Daneshmand, Siamak
    Spiess, Philippe E.
    Black, Peter C.
    EUROPEAN UROLOGY, 2015, 67 (02) : 241 - 249
  • [28] Neoadjuvant chemotherapy in the treatment of muscle invasive bladder cancer with mixed histology
    Lin, James
    Whalen, Michael
    Holder, Dara
    Hruby, Gregory
    DeCastro, G. Joel
    McKiernan, James
    CANADIAN JOURNAL OF UROLOGY, 2013, 20 (02) : 6690 - 6695
  • [29] Neoadjuvant versus adjuvant chemotherapy for muscle-invasive bladder cancer
    Clark, Peter E.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (06) : 821 - 830
  • [30] Adjuvant and neoadjuvant chemotherapy in muscle invasive bladder cancer: Literature review
    Pectasides, D
    Pectasides, M
    Nikolaou, M
    EUROPEAN UROLOGY, 2005, 48 (01) : 60 - 68